# Evaluating DFPP for Microplastic and PFAS Reduction

> clinical trial · VERIFIED · 2026-07-24

Status: ENROLLING_BY_INVITATION · Sponsor: Proxima Health, Inc. · Condition: Microplastic and Nanoplastic Particle Burden in Peripheral Blood

- Company: Proxima Health, Inc.
- Sector: Microplastic and Nanoplastic Particle Burden in Peripheral Blood
- Primary source: https://clinicaltrials.gov/study/NCT07658443

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.